A massively parallel neuromorphic computer, known as SpiNNaker, has been used to perform a brain simulation on par with the best results obtained on a conventional supercomputer.
Computer scientists from Stanford University have developed a convolutional neural network that can predict side effects when drugs are taken in combination.
Episode 233: Addison Snell and Michael Feldman discuss the European exascale initiative and Intersect360 Research's HPC market overview.
The Blue Brain Project has deployed its fifth-generation supercomputer to support its mission of simulating an entire mammalian brain by 2020.
Chinese chipmaker Hygon is now manufacturing Zen-based x86 CPUs using a licensing agreement it signed with AMD in 2016.
The European Processor Initiative (EPI), an ambitious program to develop a pair of chips for domestic supercomputers, is poised to change the way Europe does HPC. And although the work is still very much in its early stages, it looks like the Europeans have selected their preferred processor architectures: Arm and RISC-V.
The first module of JUWELS, a supercomputer that is expected to be a model for future exascale systems, is now up and running at the Jlich Supercomputing Centre (JSC).
ANSYS, Cray, and a university researcher have conducted the first aerodynamic simulations of a full peloton of road cyclists, yielding some unexpected results.
Researchers at the Great Western 4 (GW4) Alliance have benchmarked the Cavium ThunderX2 processor that will soon power the Isambard supercomputer. But the most significant advantage of the Arm processor may have nothing to do with performance numbers.
According to the two leading analyst firms covering the high performance computing market, the use of the cloud for HPC workloads is looking a lot more attractive to users these days.
